review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0301-0082(96)00033-0 |
P698 | PubMed publication ID | 9004349 |
P2093 | author name string | Hamel E | |
Cohen Z | |||
Lacombe P | |||
Bonvento G | |||
P2860 | cites work | Comparison of density of sympathetic varicosities and their closeness to smooth muscle cells in rabbit middle cerebral and ear arteries and their branches | Q72711379 |
Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine | Q78919655 | ||
On the Regulation of the Blood-supply of the Brain | Q24554227 | ||
Cloning and functional characterization of the human 5-HT2B serotonin receptor | Q28251302 | ||
5-HT2 receptor antagonists and migraine therapy | Q28282073 | ||
Expression of serotonin receptor mRNAs in blood vessels | Q28296354 | ||
Prostaglandins and vasoactive amines in cerebral vasospasm after aneurysmal subarachnoid hemorrhage | Q28339510 | ||
Serotonin nerve terminals in adult rat neocortex | Q30828991 | ||
The 5-hydroxytryptamine antagonist ketanserin inhibits the vasoconstrictor activity of per-operative CSF, from subarachnoid haemorrhage patients, on isolated tissues | Q33618519 | ||
Does the release of potassium from astrocyte endfeet regulate cerebral blood flow? | Q34050302 | ||
The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. | Q34062645 | ||
Serotonin content of some mammalian tissues and urine and a method for its determination | Q34233627 | ||
Experimental CNS ischemia: Serotonin antagonists reduce or prevent damage | Q34247923 | ||
Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin | Q34719639 | ||
Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development | Q35189866 | ||
Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine | Q35234469 | ||
Autonomic control of neuronal-astrocytic interactions, regulating metabolic activities, and ion fluxes in the CNS | Q35367098 | ||
Stimulation of aortic smooth muscle cell mitogenesis by serotonin | Q35588425 | ||
GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein | Q35755724 | ||
Effects of sumatriptan on the cerebral intraparenchymal microcirculation in the cat. | Q36330113 | ||
Alterations in serotonin and neuropeptide Y content of cerebrovascular sympathetic nerves following experimental subarachnoid hemorrhage. | Q52246294 | ||
5-Hydroxytryptamine demonstrated immunohistochemically in rat cerebrovascular nerves largely represents 5-hydroxytryptamine uptake into sympathetic nerve fibres. | Q52248234 | ||
Stimulation of glycogenolysis in astrocytes by fluoxetine, an antidepressant acting like 5-HT | Q53810734 | ||
Serotonin-synthesizing nerve fibers in rat and cat cerebral arteries and arterioles: immunohistochemistry of tryptophan-5-hydroxylase | Q57043683 | ||
The effect of p-chlorophenylalanine on cerebral metabolism and biogenic amine content of traumatized brain | Q57043912 | ||
Fluoxetine effects on cerebral glucose metabolism | Q57774429 | ||
Dose-dependent effects of buspirone on behavior and cerebral glucose metabolism in rats | Q57834606 | ||
MECHANISM OF MIGRAINE HEADACHE AND ACTION OF ERGOTAMINE TARTRATE | Q64410891 | ||
Functional consequences of unilateral lesion of the locus coeruleus: a quantitative [14C]2-deoxyglucose investigation. | Q64905942 | ||
Immunohistochemical and electron microscopic demonstration of vascular innervation in the mammalian brainstem | Q64955252 | ||
Serotonin Neurons Project to Small Blood Vessels in the Brain | Q66933529 | ||
Regulation of regional cerebral blood flow by cholinergic fibers originating in the basal forebrain | Q67507823 | ||
Neuroanatomical structures involved in the action of the 5-HT3 antagonist ondansetron: a 2-deoxyglucose autoradiographic study in the rat | Q67898501 | ||
Origin and postnatal development of nerves showing 5-hydroxytryptamine-like immunoreactivity supplying major cerebral arteries of the rat | Q68183987 | ||
Kinetic studies on uptake of serotonin and noradrenaline into pial arteries of rats | Q68699973 | ||
Serotonin as an alternative transmitter in sympathetic nerves of large cerebral arteries of the rabbit | Q68949497 | ||
Effects of electrical stimulation of the dorsal raphe nucleus on local cerebral blood flow in the rat | Q69600203 | ||
Cerebral arterial spasm. 2. In vitro contractile activity of serotonin in human serum and CSF on the canine basilar artery, and its blockage by methylsergide and phenoxybenzamine | Q69738851 | ||
Electron microscopic evidence for innervation of intracerebral arterioles in the cat | Q69818328 | ||
Adrenergic, serotoninergic, histaminergic, and imipramine binding sites in post-mortal human cerebral microvessel preparations | Q69928968 | ||
Differential patterns of local cerebral glucose utilization in response to 5-hydroxytryptamine agonists | Q70059263 | ||
Lesion of the dorsal raphe nucleus induces supersensitivity to serotonin in isolated cat middle cerebral artery | Q70135393 | ||
Ultrastructural distribution of vasodilator and constrictor nerves in cat cerebral arteries | Q70903681 | ||
Activation of glycogen phosphorylase by serotonin and 3,4-methylenedioxymethamphetamine in astroglial-rich primary cultures: involvement of the 5-HT2A receptor | Q72033044 | ||
Regulation of blood-brain barrier endothelial cells by nitric oxide | Q72133133 | ||
Effects of serotonergic drugs in experimental brain ischemia: evidence for a protective role of serotonin in cerebral ischemia | Q72269238 | ||
Enhanced cerebrovascular responsiveness to hypercapnia following depletion of central serotonergic terminals | Q72333950 | ||
Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma | Q72393651 | ||
Serotonin axons in the supra- and subependymal plexuses and in the leptomeninges; their roles in local alterations of cerebrospinal fluid and vasomotor activity | Q48406288 | ||
Protective effects of serotonin reuptake inhibitors, citalopram and clomipramine, against hippocampal CA1 neuronal damage following transient ischemia in the gerbil | Q48432155 | ||
Capillary innervation in the mammalian central nervous system: An electron microscopic demonstration | Q48437895 | ||
Neurochemical studies on the existence, origin and characteristics of the serotonergic innervation of small pial vessels | Q48445044 | ||
Regulation of cortical blood flow by the dorsal raphe nucleus: topographic organization of cerebrovascular regulatory regions | Q48459113 | ||
Serotonergic innervation of cat cerebral arteries | Q48470714 | ||
Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain | Q48507790 | ||
Effect of stimulation of nucleus raphe dorsalis on carotid blood flow. I. The monkey | Q48526929 | ||
Effect of stimulation of nucleus raphe dorsalis on carotid blood flow. II. The cat. | Q48532879 | ||
Cell-cell junctional interactions and characteristic plasma membrane features of cultured rat glial cells | Q48533067 | ||
5-Hydroxytryptamine innervation of vessels in the rat cerebral cortex. Immunohistochemical findings and hydrogen clearance study of rCBF. | Q48562555 | ||
Serotonin uptake by astrocytes in situ | Q48587504 | ||
Effects of dorsal raphe stimulation on cerebral glucose utilization in the anaesthetized rat. | Q48608081 | ||
Perivascular serotoninergic neurons: Somatodendritic contacts and axonic innervation of blood vessels | Q48612313 | ||
A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat | Q48622884 | ||
Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat. | Q48675911 | ||
Cerebrovascular and functional consequences of 5-HT1A receptor activation | Q48686602 | ||
Central serotonergic nerves project to the pial vessels of the brain. | Q48716042 | ||
Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive young rats | Q48765198 | ||
Dose- and time-dependent effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a serotonergic 5-HT2 receptor agonist, on local cerebral glucose metabolism in awake rats | Q48795452 | ||
Evidence for a possible role for serotonergic systems in the control of cerebral blood flow | Q48832430 | ||
Changes in the serotonergic system during the sleep-wake cycle: simultaneous polygraphic and voltammetric recordings in hypothalamus using a telemetry system. | Q48856924 | ||
Extracellular levels of serotonin in the medial pontine reticular formation in relation to sleep-wake cycle in cats: a microdialysis study | Q48859685 | ||
Effect of apomorphine on the relationship between local cerebral glucose utilization and local cerebral blood flow (with an appendix on its statistical analysis). | Q48866330 | ||
Serotonin as a neurotransmitter in cerebral arteries | Q48896740 | ||
Glycogenolysis induced by serotonin in brain: identification of a new class of receptor | Q48921354 | ||
Cerebral circulatory response to hypercapnia: effects of lesions of central dopaminergic and serotoninergic neuron systems | Q49129092 | ||
Serotonin uptake into cerebrovascular nerve fibers of rat, visualization by immunohistochemistry, disappearance following sympathectomy, and release during electrical stimulation. | Q51751077 | ||
Structure and function of the brain serotonin system | Q36741599 | ||
Effect of chemical stimulation of the dorsal raphe nucleus on cerebral blood flow in rat. | Q36792856 | ||
5-HT receptors in human and animal cerebrovasculature | Q37506150 | ||
Cholecystokinin-immunoreactive neurons in rat and monkey cerebral cortex make symmetric synapses and have intimate associations with blood vessels | Q37609678 | ||
Statistical issues in the analysis of neuroimages | Q37647768 | ||
The concept of coupling blood flow to brain function: revision required? | Q39464841 | ||
Cathecholamine and 5-hydroxytryptamine levels in ischemic brain. Influence of p-chlorophenylalanine | Q39813400 | ||
Chemical-feedback regulation of serotonin-containing neurons in brain | Q39886099 | ||
Enhanced vesicular transport of exogenous peroxidase across cerebral vessels, induced by serotonin | Q39940113 | ||
Receptors on astrocytes--what possible functions? | Q40548718 | ||
Receptors for neurotransmitters on astrocytes in the mammalian central nervous system | Q40708560 | ||
An animal behavior model for studying central serotonergic synapses | Q40776985 | ||
The versatility of microvascular pericytes: from mesenchyme to smooth muscle? | Q40894570 | ||
Metabolic coupling between glia and neurons. | Q40943523 | ||
Changes in blood-brain barrier and cerebral blood flow following elevation of circulating serotonin level in anesthetized rats | Q41235705 | ||
Effect of the serotonin antagonist ketanserin on the hemodynamic and morphological consequences of thrombotic infarction | Q41280850 | ||
Differential expression of alpha-actin mRNA and immunoreactive protein in brain microvascular pericytes and smooth muscle cells | Q41432363 | ||
Influence of ascending serotonergic pathways on glucose use in the conscious rat brain. I. Effects of electrolytic or neurotoxic lesions of the dorsal and/or median raphé nucleus | Q41435719 | ||
Sumatriptan and cerebral perfusion in healthy volunteers | Q42111540 | ||
Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists | Q42216778 | ||
Differential proliferative response of human and mouse astrocytes to gamma-interferon | Q42457396 | ||
Cerebrovascular nerve fibers immunoreactive for tryptophan-5-hydroxylase in the rat: distribution, putative origin and comparison with sympathetic noradrenergic nerves. | Q42457987 | ||
Cholinergic basal forebrain neurons project to cortical microvessels in the rat: electron microscopic study with anterogradely transported Phaseolus vulgaris leucoagglutinin and choline acetyltransferase immunocytochemistry. | Q42474187 | ||
Ultrastructural analysis of tryptophan hydroxylase immunoreactive nerve terminals in the rat cerebral cortex and hippocampus: their associations with local blood vessels. | Q42481715 | ||
Light and electron microscopic immunocytochemical analysis of the neurovascular relationships of choline acetyltransferase and vasoactive intestinal polypeptide nerve terminals in the rat cerebral cortex | Q42495295 | ||
Neuronal and endothelial sites of acetylcholine synthesis and release associated with microvessels in rat cerebral cortex: ultrastructural and neurochemical studies | Q42519502 | ||
Ischemia-induced extracellular release of serotonin plays a role in CA1 neuronal cell death in rats | Q43914196 | ||
Ultrastructural evidence for central monoaminergic innervation of blood vessels in the paraventricular nucleus of the hypothalamus | Q43963762 | ||
Effects of the 5-HT1A partial agonists gepirone, ipsapirone and buspirone on local cerebral glucose utilization in the conscious rat. | Q44173673 | ||
Evidence for differing origins of the serotonergic innervation of major cerebral arteries and small pial vessels in the rat. | Q44504151 | ||
Induction of migrainelike headaches by the serotonin agonist m-chlorophenylpiperazine | Q44729141 | ||
Do raphe nuclei of the reticular formation have a neurosecretory or vascular sensor function? | Q45070413 | ||
Time courses of behavioral and regional cerebral metabolic responses to different doses of meta-chlorophenylpiperazine in awake rats | Q45171346 | ||
Evidence for coexistence of serotonin and noradrenaline in sympathetic nerves supplying brain vessels of guinea pig. | Q46204184 | ||
Calcium Channels and Nifedipine Inhibition of Serotonin-Induced [3H]Thymidine Incorporation in Cultured Cerebral Smooth Muscle Cells | Q46527861 | ||
Influence of ascending serotonergic pathways on glucose use in the conscious rat brain. II. Effects of electrical stimulation of the rostral raphé nuclei | Q48098913 | ||
Modulation of cortical neuronal activity by a serotonergic agent: a PET study in humans | Q48121440 | ||
Tryptophan hydroxylase activity in rat brain base arteries related to innervation originating from the dorsal raphe nucleus | Q48127451 | ||
Effect of the 5-HT1A receptor agonist ipsapirone on the local cerebral glucose utilization of the rat hippocampus | Q48171363 | ||
A brainstem atlas of catecholaminergic neurons and serotonergic perikarya in a pygmy primate (Cebuella pygmaea) | Q48216245 | ||
Methiothepin reduces glucose utilization in forebrain regions of awake rats | Q48249618 | ||
Effects of dorsal raphe nucleus stimulation on cerebral blood flow and flow-metabolism coupling in the conscious rat. | Q48254223 | ||
Localization of 5-HT1A receptors to astroglial cells in adult rats: implications for neuronal-glial interactions and psychoactive drug mechanism of action | Q48262054 | ||
Detection of 5-hydroxytryptamine2 receptors by radioligand binding, northern blot analysis, and Ca2+ responses in rat primary astrocyte cultures | Q48266643 | ||
5-HT-containing nerves to major cerebral arteries of the gerbil originate in the superior cervical ganglia | Q48290213 | ||
Effect of rat subarachnoid hemorrhage on serotonin innervation of the cerebral ventricular wall and serotonin neurons of the ventral surface of the brain stem: an immunohistochemical study | Q48338940 | ||
Neurotensin in the rat parabrachial region: ultrastructural localization and extrinsic sources of immunoreactivity | Q48343241 | ||
Absence of serotonergic innervation from raphe nuclei in rat cerebral blood vessels—I. Histological evidence | Q48343731 | ||
Time- and dose-dependent effects of the serotonergic agent quipazine on regional cerebral metabolism in rats | Q48346017 | ||
The tricyclic antidepressant clomipramine dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats | Q48389932 | ||
Local cerebral glucose utilisation following indoleamine- and piperazine-containing 5-hydroxytryptamine agonists | Q48391903 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 335-362 | |
P577 | publication date | 1996-11-01 | |
P1433 | published in | Progress in Neurobiology | Q15716615 |
P1476 | title | Serotonin in the regulation of brain microcirculation | |
P478 | volume | 50 |
Q21129349 | "You Shall Not Pass"-tight junctions of the blood brain barrier |
Q48381656 | A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users |
Q34422275 | Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice |
Q36153338 | Activation of cortical 5-HT(3) receptor-expressing interneurons induces NO mediated vasodilatations and NPY mediated vasoconstrictions. |
Q39005977 | Age-associated physiological and pathological changes at the blood-brain barrier: A review. |
Q35663954 | Astrocyte regulation of blood flow in the brain |
Q44973601 | Astrocytic cytochromes p450: an enzyme subfamily critical for brain metabolism and neuroprotection |
Q42444002 | Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex |
Q42492840 | Basal forebrain nitric oxide synthase (NOS)-containing neurons project to microvessels and NOS neurons in the rat neocortex: cellular basis for cortical blood flow regulation |
Q84979020 | Biological sciences related to headache |
Q26864317 | Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke |
Q34384307 | Blood-brain barrier integrity may be threatened by exercise in a warm environment |
Q42002170 | Blood-brain barrier regulation: Environmental cues controlling the onset of barrier properties |
Q39421349 | Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood-brain barrier permeability |
Q31968697 | Calcium antagonists decrease capillary wall damage in aging hypertensive rat brain |
Q36801092 | Cell-cell signaling in the neurovascular unit |
Q26827093 | Cell-culture models of the blood-brain barrier |
Q48663991 | Cerebral Hypoperfusion and the Energy Deficit in Alzheimer's Disease |
Q34224715 | Cerebral microvascular pathology in aging and Alzheimer's disease |
Q36890698 | Cerebrovascular consequences of altering serotonergic transmission in conscious rat. |
Q33633462 | Chronic cerebrovascular dysfunction after traumatic brain injury |
Q30847706 | Contributions and complexities from the use of in vivo animal models to improve understanding of human neuroimaging signals. |
Q37652820 | Controversies and evolving new mechanisms in subarachnoid hemorrhage. |
Q45105989 | Cortical GABA interneurons in neurovascular coupling: relays for subcortical vasoactive pathways. |
Q37216396 | Current and prospective pharmacological targets in relation to antimigraine action |
Q40885646 | Cyclic adenosine monophosphate regulates the expression of the intercellular adhesion molecule and the inducible nitric oxide synthase in brain endothelial cells |
Q21129285 | Deciphering the Neuronal Circuitry Controlling Local Blood Flow in the Cerebral Cortex with Optogenetics in PV::Cre Transgenic Mice |
Q35787090 | Differential modulation of the default mode network via serotonin-1A receptors |
Q41677002 | Diffuse transmission by acetylcholine in the CNS. |
Q35045324 | Dihydroergotamine and its metabolite, 8'-hydroxy-dihydroergotamine, as 5-HT1A receptor agonists in the rat brain |
Q40346595 | Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study |
Q73526592 | Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study |
Q46435462 | Effect of increased serotonin levels on [18F]MPPF binding in rat brain: fenfluramine vs the combination of citalopram and ketanserin |
Q35895888 | Effects of MDMA on sociability and neural response to social threat and social reward |
Q44262092 | Effects of aging on brain perfusion and serotonin-2A receptor binding in the normal canine brain measured with single photon emission tomography. |
Q34508144 | Effects of medications on cerebral blood flow in late-life depression |
Q73189971 | Effects of the specific serotonin reuptake inhibitor, citalopram, upon local cerebral blood flow and glucose utilisation in the rat |
Q47715791 | Endothelial expression of the 5-hydroxytryptamine1B antimigraine drug receptor in rat and human brain microvessels |
Q35667573 | Fibrinogen-induced increased pial venular permeability in mice |
Q44314756 | Flavonoid modulation of ionic currents mediated by GABA(A) and GABA(C) receptors |
Q30615041 | Functional neuroimaging of normal human sleep by positron emission tomography |
Q36983682 | Glial regulation of the cerebral microvasculature |
Q38436592 | Headache, cerebral aneurysms, and the use of triptans and ergot derivatives |
Q41547016 | Hemodynamic variability in soldiers with trauma: Implications for functional MRI connectivity studies. |
Q31154789 | How do antidepressants influence the BOLD signal in the developing brain? |
Q36363322 | Hypertrophic scar regression is linked to the occurrence of endothelial dysfunction |
Q38746011 | Identification of two phosphorylation sites essential for annexin A1 in blood-brain barrier protection after experimental intracerebral hemorrhage in rats. |
Q78440673 | Influence of the serotonin antagonist, metergoline, on the anxiogenic effects of carbon dioxide, and on heart rate and neuroendocrine measures, in healthy volunteers |
Q44269425 | Insulin-like growth factor-1 secreted by brain microvascular endothelial cells attenuates neuron injury upon ischemia |
Q34982523 | Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach |
Q48467208 | Investigation of the mechanisms mediating MDMA "Ecstasy"-induced increases in cerebro-cortical perfusion determined by btASL MRI. |
Q36422248 | Is serotonin hyperalgesic or analgesic? |
Q40700830 | Localization of norepinephrine and serotonin transporter in mouse brain capillary endothelial cells |
Q36965878 | MDMA 'ecstasy' increases cerebral cortical perfusion determined by bolus-tracking arterial spin labelling (btASL) MRI |
Q51007101 | MDMA intoxication and verbal memory performance: a placebo-controlled pharmaco-MRI study. |
Q39238290 | Mechanisms Mediating Functional Hyperemia in the Brain |
Q34871489 | Mechanisms of hyperammonemia |
Q47793574 | Migraine: possible role of shear-induced platelet aggregation with serotonin release. |
Q37523317 | Molecular contributions to neurovascular unit dysfunctions after brain injuries: lessons for target-specific drug development |
Q47836714 | Monoamine neurotransmitters and amino acids in the cerebrum and striatum of immature rats with kaolin-induced hydrocephalus. |
Q48350883 | Monoamine neurotransmitters and their metabolites in the mature rabbit brain following induction of hydrocephalus. |
Q38139823 | Monocyte chemoattractant protein-1 and the blood-brain barrier |
Q42476599 | Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization |
Q37594138 | N-acetyl-serotonin offers neuroprotection through inhibiting mitochondrial death pathways and autophagic activation in experimental models of ischemic injury. |
Q77295945 | Neurogenic control of the cerebral microcirculation: is dopamine minding the store? |
Q36539089 | Neuroimaging research in human MDMA users: a review |
Q44594919 | Neuronal and astrocytic responses involving the serotonergic system in human spongiform encephalopathies |
Q35010538 | Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines |
Q40717603 | Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain |
Q37988811 | Neurovascular unit: a focus on pericytes |
Q34784409 | Noradrenergic regulation of inflammatory gene expression in brain. |
Q58081333 | Nutritional supplementation boosts aerobic exercise effects on functional brain systems |
Q48320138 | PET measurement of serotonin transporter occupancy: a comparison of escitalopram and citalopram |
Q44010205 | Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users |
Q39156246 | Pericytes impair capillary blood flow and motor function after chronic spinal cord injury |
Q36391631 | Perivascular nerves and the regulation of cerebrovascular tone |
Q34229087 | Pharmacologic magnetic resonance imaging (phMRI): imaging drug action in the brain |
Q35510178 | Potassium channels and neurovascular coupling |
Q26776154 | Potential of Neural Stem Cell-Based Therapy for Parkinson's Disease |
Q43115549 | Pressure-dependent contribution of Rho kinase-mediated calcium sensitization in serotonin-evoked vasoconstriction of rat cerebral arteries |
Q35907475 | Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good |
Q35936959 | Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers |
Q35052965 | Purinergic control of vascular tone in the retina |
Q31154008 | Recent advances in blood-brain barrier disruption as a CNS delivery strategy |
Q42474212 | Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer's disease |
Q42844031 | Regulation of cerebral blood flow |
Q35817868 | Regulation of myogenic tone and structure of parenchymal arterioles by hypertension and the mineralocorticoid receptor |
Q33972731 | Revisiting the role of neurons in neurovascular coupling |
Q26995130 | Role of fibrinogen in cerebrovascular dysfunction after traumatic brain injury |
Q46301762 | Secondhand cigarette smoke exposure causes upregulation of cerebrovascular 5-HT(1) (B) receptors via the Raf/ERK/MAPK pathway in rats |
Q34658800 | Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure |
Q36544155 | Serotonergic mechanisms in amyotrophic lateral sclerosis |
Q35777635 | Serotonergic neurons as carbon dioxide sensors that maintain pH homeostasis |
Q34655338 | Serotonin and migraine: biology and clinical implications |
Q48326644 | Serotonin depletion can enhance the cerebrovascular responses induced by cortical spreading depression via the nitric oxide pathway |
Q47965497 | Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine? |
Q37114969 | Serotonin transporter genotype and depressive phenotype determination by discriminant analysis of glucose metabolism under acute tryptophan depletion |
Q73196400 | Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging |
Q28345813 | Sumatriptan elicits both constriction and dilation in human and bovine brain intracortical arterioles |
Q33374696 | Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users |
Q35855634 | Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery |
Q34739040 | Targeting the murine serotonin transporter: insights into human neurobiology. |
Q30659465 | The BOLD signal and neurovascular coupling in autism |
Q40360036 | The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. |
Q60045414 | The Neuroprotective Effects of Exercise: Maintaining a Healthy Brain Throughout Aging |
Q47257826 | The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease |
Q35586685 | The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties |
Q34991028 | The cerebral glucose-fatty acid cycle: evolutionary roots, regulation, and (patho)physiological importance |
Q38413900 | The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory |
Q34790113 | The effects of hypertension on the cerebral circulation |
Q50187880 | The effects of obesity on the cerebral vasculature |
Q48284194 | The induction of pain: an integrative review |
Q31149649 | The micro-architecture of the cerebral cortex: functional neuroimaging models and metabolism |
Q30748114 | The neural basis of functional brain imaging signals |
Q33805295 | The neurovascular unit in brain function and disease. |
Q34205139 | The physiology of developmental changes in BOLD functional imaging signals. |
Q89671982 | The serotonin 2A receptor agonist 25CN-NBOH increases murine heart rate and neck-arterial blood flow in a temperature-dependent manner |
Q42169859 | The use of pharmacological-challenge fMRI in pre-clinical research: application to the 5-HT system |
Q36676983 | The vascular neural network--a new paradigm in stroke pathophysiology |
Q34588901 | Time series fMRI measures detect changes in pontine raphé following acute tryptophan depletion |
Q28729033 | Transcriptional profiling of human brain endothelial cells reveals key properties crucial for predictive in vitro blood-brain barrier models |
Q37264505 | Transient receptor potential channel 1/4 reduces subarachnoid hemorrhage-induced early brain injury in rats via calcineurin-mediated NMDAR and NFAT dephosphorylation |
Q27690256 | Transporters at CNS barrier sites: obstacles or opportunities for drug delivery? |
Q27011768 | Use of magnetic resonance imaging in pharmacogenomics |
Q35551681 | Vascular Protection Following Cerebral Ischemia and Reperfusion |
Q33639014 | Vascular neural network phenotypic transformation after traumatic injury: potential role in long-term sequelae |
Q86029497 | Vasotrophic regulation of age-dependent hypoxic cerebrovascular remodeling |
Q33819827 | White Matter Injury and Recovery after Hypertensive Intracerebral Hemorrhage |
Q34587647 | eae36, a locus on mouse chromosome 4, controls susceptibility to experimental allergic encephalomyelitis in older mice and mice immunized in the winter |
Search more.